Skip to main content


Front. Med., 19 July 2021
Sec. Infectious Diseases – Surveillance, Prevention and Treatment
This article is part of the Research Topic Coronavirus Disease (COVID-19): Pathophysiology, Epidemiology, Clinical Management and Public Health Response, Volume II View all 165 articles

RETRACTED: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

\r\nJohn McCoy
John McCoy1*Andy GorenAndy Goren1Flvio Adsuara Cadegiani,Flávio Adsuara Cadegiani1,2Sergio Vao-GalvnSergio Vaño-Galván3Maja KovacevicMaja Kovacevic4Mirna SitumMirna Situm4Jerry ShapiroJerry Shapiro5Rodney SinclairRodney Sinclair6Antonella TostiAntonella Tosti7Andrija StanimirovicAndrija Stanimirovic8Daniel FonsecaDaniel Fonseca9Edinete DornerEdinete Dorner9Dirce Costa OnetyDirce Costa Onety9Ricardo Ariel ZimermanRicardo Ariel Zimerman10Carlos Gustavo WambierCarlos Gustavo Wambier11
  • 1Applied Biology, Inc. Irvine, CA, United States
  • 2Department of Endocrinology, Corpometria Institute, Brasilia, Brazil
  • 3Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain
  • 4Department of Dermatology and Venereology, University Hospital Center “Sestre Milosrdnice”, Zagreb, Croatia
  • 5Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States
  • 6Sinclair Dermatology, Melbourne, VIC, Australia
  • 7Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, United States
  • 8School of Medicine, European University Cyprus, Nicosia, Cyprus
  • 9Intensive Care Unit, Samel Hospital, Manaus, Brazil
  • 10Hospital da Brigada Militar, Porto Alegre, Brazil
  • 11Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, United States

Citation: McCoy J, Goren A, Cadegiani FA, Vaño-Galván S, Kovacevic M, Situm M, Shapiro J, Sinclair R, Tosti A, Stanimirovic A, Fonseca D, Dorner E, Onety DC, Zimerman RA and Wambier CG (2021) Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial. Front. Med. 8:668698. doi: 10.3389/fmed.2021.668698

Received: 17 February 2021; Accepted: 11 June 2021;
Published: 19 July 2021; Retracted: 10 June 2022.

Edited by:

Zisis Kozlakidis, International Agency For Research on Cancer (IARC), France

Reviewed by:

Chao Ren, First Hospital Affiliated to the Chinese PLA General Hospital, China
Olufemi Babalola, ECWA Bingham University, Nigeria

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.